SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017454
Filing Date
2019-11-14
Accepted
2019-11-14 16:06:18
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 420269
2 ex31-1.htm EX-31.1 39124
3 ex32-1.htm EX-32.1 14351
  Complete submission text file 0001493152-19-017454.txt   2490129

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20190930.xml EX-101.INS 372174
5 XBRL SCHEMA FILE vbio-20190930.xsd EX-101.SCH 37094
6 XBRL CALCULATION FILE vbio-20190930_cal.xml EX-101.CAL 42283
7 XBRL DEFINITION FILE vbio-20190930_def.xml EX-101.DEF 96099
8 XBRL LABEL FILE vbio-20190930_lab.xml EX-101.LAB 254148
9 XBRL PRESENTATION FILE vbio-20190930_pre.xml EX-101.PRE 183585
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 191220055
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services